The estimated Net Worth of Douglas L Braunstein is at least $12.1 Million dollars as of 9 May 2019. Douglas Braunstein owns over 159,223 units of Eagle Pharmaceuticals Inc stock worth over $3,027,928 and over the last 8 years Douglas sold EGRX stock worth over $9,045,459.
Douglas has made over 3 trades of the Eagle Pharmaceuticals Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Douglas sold 159,223 units of EGRX stock worth $9,045,459 on 9 May 2019.
The largest trade Douglas's ever made was buying 2,899,391 units of Eagle Pharmaceuticals Inc stock on 12 March 2019 worth over $4,001,160. On average, Douglas trades about 162,053 units every 34 days since 2016. As of 9 May 2019 Douglas still owns at least 811,777 units of Eagle Pharmaceuticals Inc stock.
You can see the complete history of Douglas Braunstein stock trades at the bottom of the page.
Douglas's mailing address filed with the SEC is HUDSON EXECUTIVE CAPITAL LP, 570 LEXINGTON AVENUE, 35TH FLOOR, NEW YORK, NY, 10022.
Over the last 11 years, insiders at Eagle Pharmaceuticals Inc have traded over $188,911,314 worth of Eagle Pharmaceuticals Inc stock and bought 1,029,065 units worth $16,655,732 . The most active insiders traders include Executive Capital Lphec Man..., Douglas L Braunstein, and Investments Iv, L.P.Pro Que.... On average, Eagle Pharmaceuticals Inc executives and independent directors trade stock every 43 days with the average trade being worth of $193,721. The most recent stock trade was executed by Scott Tarriff on 1 November 2023, trading 21,619 units of EGRX stock currently worth $299,207.
Eagle Pharmaceuticals Inc executives and other stock owners filed with the SEC include: